Anebulo Pharmaceuticals, Inc. logo ANEB - Anebulo Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 3
HOLD 1
SELL 0
STRONG
SELL 0
| PRICE TARGET: $6.00 DETAILS
HIGH: $6.00
LOW: $6.00
MEDIAN: $6.00
CONSENSUS: $6.00
UPSIDE: 1204.35%
Annual Quarterly
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4
Revenue
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses
R&D Expenses 1.2 0.8 1.1 0.6 1.2 1.3 0.5 0.7 1.1 1.3 1.4 1.1 1.9 1.2 1.1 0.9 0.2 0.7 1.8 0.3 0.2 0.0 0.1
SG&A Expenses 1.5 1.5 1.2 1.3 1.4 1.1 0.9 0.9 1.7 1.3 1.1 1.8 1.9 1.4 1.2 1.0 0.9 0.8 0.7 0.3 0.2 0.2 0.0
Other Expenses 0 0 0 0 0 0 0 0 (0.0) 0.0 0 0 0 0 0 0 0 0 (0.0) 0 0 0 0
Operating Expenses 2.6 2.3 2.3 1.9 2.6 2.4 1.3 1.7 2.8 2.5 2.5 2.9 3.8 2.6 2.3 1.9 1.1 1.6 2.5 0.6 0.3 0.3 0.2
Operating Income
Operating Income (2.6) (2.3) (2.3) (1.9) (2.6) (2.4) (1.3) (1.7) (2.8) (2.5) (2.5) (2.9) (3.8) (2.6) (2.3) (1.9) (1.1) (1.6) (2.5) (0.6) (0.3) (0.3) (0.2)
Interest Expense 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0 0 0 0 0 0.0 0 0 0 0 0.0 0 0 0.0
Interest Income 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0 0.1 0.0 0 0.0 0 0 0 0.0 0 0 0 0
Profitability
EBITDA (2.6) (2.1) (2.1) (1.4) (2.4) (1.9) (1.3) (1.6) (2.7) 0.1 (2.5) (2.7) (3.8) (2.6) (2.3) (1.9) (1.1) (1.6) (26.6) (0.6) 0 0 (0.2)
EBIT (2.6) (2.1) (2.1) (1.4) (2.4) (2.1) (1.3) (1.6) (2.7) (2.5) (2.5) (2.8) (3.8) (2.6) (2.3) (1.9) (1.1) (1.6) (29.1) (0.6) (0.3) (0.3) (0.2)
Income Before Tax (2.0) (2.2) (2.1) (1.7) (2.5) (2.2) (1.3) (1.7) (2.7) (2.5) (2.5) (2.8) (3.8) (2.6) (2.3) (1.9) (1.1) (1.6) (29.1) (0.6) (0.3) (0.3) (0.2)
Income Tax Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income (2.0) (2.2) (2.1) (1.7) (2.5) (2.2) (1.3) (1.7) (2.7) (2.5) (2.5) (2.8) (3.8) (2.6) (2.3) (1.9) (1.1) (1.6) (29.1) (0.6) (0.3) (0.3) (0.2)
Per Share Data
EPS (Basic) -0.05 -0.05 -0.05 -0.04 -0.09 -0.08 -0.05 -0.06 -0.11 -0.10 -0.10 -0.11 -0.15 -0.11 -0.10 -0.08 -0.05 -0.07 -1.59 -0.38 -0.01 -0.01 -0.01
EPS (Diluted) -0.05 -0.05 -0.05 -0.06 -0.09 -0.08 -0.05 -0.06 -0.11 -0.10 -0.10 -0.11 -0.15 -0.11 -0.10 -0.08 -0.05 -0.07 -1.59 -0.38 -0.01 -0.01 -0.01
Shares Outstanding 41.1 41.1 41.1 27.4 27.4 25.9 25.8 25.9 25.8 25.6 25.1 25.6 25.6 23.4 23.3 23.3 23.3 23.3 23.3 23.3 23.3 23.3 23.7
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4
Current Assets
Cash & Cash Equivalents 9.0 10.4 11.6 13.3 15.0 1.4 3.1 5.1 6.6 8.5 11.2 14.2 16.4 19.2 14.5 16.5 18.0 19.2 20.0 3.3 2.5 (3.0) 3.0
Short-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6.0 0
Net Receivables 0.1 0.0 0 0 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 0 0 0.1 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0.6 0 0 0
Total Current Assets 9.3 10.5 12.0 13.8 15.4 2.0 3.5 5.4 6.8 9.0 11.7 14.4 16.9 19.8 15.6 17.2 19.0 20.5 21.7 3.9 2.5 3.0 3.0
Non-Current Assets
Property, Plant & Equipment 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 0.1 0.2 0.2 0.2 0.4 0.5 0.6 0.6 0.7 0 0 0 0 0 0 0 0 0 0 0.4 0.1 (0.2) 0
Total Non-Current Assets 0.1 0.2 0.2 0.2 0.4 0.5 0.6 0.6 0.7 0 0 0 0 0 0 0 0 0 0 0.4 0.1 (0.2) 0
Total Assets 9.4 10.7 12.1 14.0 15.8 2.5 4.1 6.0 7.5 9.0 11.7 14.4 16.9 19.8 15.6 17.2 19.0 20.5 21.7 4.3 2.6 2.8 3.0
Current Liabilities
Account Payables 0.6 0.6 0.2 0.4 0.3 0.3 0.2 0.4 0.3 0.6 0.5 0.6 0.3 0.5 0.4 0.1 0.0 0.5 0.1 0.1 0.1 0 0
Short-Term Debt 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0.2
Deferred Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities (0.4) (0.4) 0 0 0.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0
Total Current Liabilities 0.6 0.6 0.5 0.5 0.9 0.6 0.3 1.0 1.0 0.7 1.1 1.5 1.4 0.7 0.5 0.1 0.0 0.6 0.2 0.3 0.4 0 0.2
Non-Current Liabilities
Long-Term Debt 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0.9 0.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5 0 0 0
Total Non-Current Liabilities 0.9 0.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5 0 0 0
Total Liabilities 1.5 1.0 0.5 0.5 0.9 0.6 0.3 1.0 1.0 0.7 1.1 1.5 1.4 0.7 0.5 0.1 0.0 0.6 0.2 10.8 0.4 0 0.2
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0.0
Retained Earnings (78.0) (76.0) (73.9) (71.7) (70.1) (67.6) (65.4) (64.1) (62.4) (59.7) (57.2) (54.7) (51.9) (48.1) (45.5) (43.1) (41.3) (40.2) (38.6) (9.5) (0.8) 0 (0.2)
Accumulated Other Comprehensive Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.2) 0
Total Stockholders' Equity 7.9 9.7 11.7 13.5 15.0 1.9 3.8 5.0 6.5 8.3 10.6 12.9 15.5 19.1 15.1 17.2 18.9 19.9 21.4 (6.5) 2.3 2.8 2.8
Total Liabilities & Equity 9.4 10.7 12.1 14.0 15.8 2.5 4.1 6.0 7.5 9.0 11.7 14.4 16.9 19.8 15.6 17.2 19.0 20.5 21.7 4.3 2.6 2.8 3.0
Debt Metrics
Total Debt 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0.2
Net Debt (9.0) (10.4) (11.6) (13.3) (15.0) (1.4) (3.1) (5.1) (6.6) (8.5) (11.2) (14.2) (16.4) (19.2) (14.5) (16.5) (18.0) (19.2) (20.0) (3.3) (2.3) 3.0 (2.8)
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1
Operating Activities
Net Income (2.0) (2.2) (2.1) (1.7) (2.5) (2.2) (1.3) (1.7) (2.7) (2.5) (2.5) (2.8) (3.8) (2.6) (2.3) (1.9) (1.1) (1.6) (29.1) (0.6) (0.3) (0.3)
Depreciation & Amortization 0 0.0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Stock-Based Compensation 0.2 0.2 0.3 0.3 0.6 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0
Change in Working Capital 0.5 0.6 0.1 (0.4) 0.4 0.2 (0.9) (0.1) 0.7 (0.5) (0.6) 0.4 1.0 0.4 0.1 0.3 (0.2) 0.7 (0.7) (0.3) (0.1) 0.1
Other Non-Cash Items 0.0 0 0.0 0 0.1 0.1 0.1 0.1 0.0 0 0 0 0 0 0 0 0 0 26.6 (0.0) 0.0 0.0
Operating Cash Flow (1.3) (1.3) (1.7) (1.6) (1.4) (1.7) (2.1) (1.5) (1.8) (2.7) (2.8) (2.2) (2.6) (2.0) (2.0) (1.5) (1.2) (0.8) (3.1) (0.8) (0.4) (0.1)
Investing Activities
Capital Expenditure 0 0 0 0 0.0 0 (0.0) 0 (0.0) 0.0 (0.0) 0 0 0 (0.0) 0.0 0.0 0.0 0 0 0 0
Acquisitions 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sales/Maturities of Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Investing Activities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Investing Cash Flow 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0 22.0 1.7 0 0
Financing Cash Flow 0 0 0 (0.1) 15 0 0 0 (0.1) 0 (0.1) 0 (0.2) 6.7 0 0 0 0 19.8 1.7 0 0
Cash Position
Net Change in Cash (1.3) (1.3) (1.7) (1.7) 13.6 (1.7) (2.1) (1.5) (1.9) (2.7) (2.9) (2.2) (2.9) 4.7 (2.0) (1.5) (1.2) (0.8) 16.7 0.8 (0.4) (0.1)
Cash at Beginning 10.4 11.6 13.3 15.0 1.4 3.1 5.1 6.6 8.5 11.2 14.2 16.4 19.2 14.5 16.5 18.0 19.2 20.0 3.3 2.5 2.9 3.0
Cash at End 9.0 10.4 11.6 13.3 15.0 1.4 3.1 5.1 6.6 8.5 11.2 14.2 16.4 19.2 14.5 16.5 18.0 19.2 20.0 3.3 2.5 2.9
Free Cash Flow (1.3) (1.3) (1.7) (1.6) (1.4) (1.7) (2.1) (1.5) (1.8) (2.7) (2.8) (2.2) (2.6) (2.0) (2.0) (1.5) (1.2) (0.8) (3.1) (0.8) (0.4) (0.1)
Key Metrics 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4
Income Statement
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Income (2.6) (2.3) (2.3) (1.9) (2.6) (2.4) (1.3) (1.7) (2.8) (2.5) (2.5) (2.9) (3.8) (2.6) (2.3) (1.9) (1.1) (1.6) (2.5) (0.6) (0.3) (0.3) (0.2)
Net Income (2.0) (2.2) (2.1) (1.7) (2.5) (2.2) (1.3) (1.7) (2.7) (2.5) (2.5) (2.8) (3.8) (2.6) (2.3) (1.9) (1.1) (1.6) (29.1) (0.6) (0.3) (0.3) (0.2)
EPS (Diluted) -0.05 -0.05 -0.05 -0.06 -0.09 -0.08 -0.05 -0.06 -0.11 -0.10 -0.10 -0.11 -0.15 -0.11 -0.10 -0.08 -0.05 -0.07 -1.59 -0.38 -0.01 -0.01 -0.01
Balance Sheet
Cash & Equivalents 9.0 10.4 11.6 13.3 15.0 1.4 3.1 5.1 6.6 8.5 11.2 14.2 16.4 19.2 14.5 16.5 18.0 19.2 20.0 3.3 2.5 (3.0) 3.0
Total Assets 9.4 10.7 12.1 14.0 15.8 2.5 4.1 6.0 7.5 9.0 11.7 14.4 16.9 19.8 15.6 17.2 19.0 20.5 21.7 4.3 2.6 2.8 3.0
Total Debt 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0.2
Stockholders' Equity 7.9 9.7 11.7 13.5 15.0 1.9 3.8 5.0 6.5 8.3 10.6 12.9 15.5 19.1 15.1 17.2 18.9 19.9 21.4 (6.5) 2.3 2.8 2.8
Cash Flow
Operating Cash Flow (1.3) (1.3) (1.7) (1.6) (1.4) (1.7) (2.1) (1.5) (1.8) (2.7) (2.8) (2.2) (2.6) (2.0) (2.0) (1.5) (1.2) (0.8) (3.1) (0.8) (0.4) (0.1)
Capital Expenditure 0 0 0 0 0.0 0 (0.0) 0 (0.0) 0.0 (0.0) 0 0 0 (0.0) 0.0 0.0 0.0 0 0 0 0
Free Cash Flow (1.3) (1.3) (1.7) (1.6) (1.4) (1.7) (2.1) (1.5) (1.8) (2.7) (2.8) (2.2) (2.6) (2.0) (2.0) (1.5) (1.2) (0.8) (3.1) (0.8) (0.4) (0.1)